NSG 6999 W2 D10 -CBD Adjunctive Therapies

NSG 6999 W2 D10 -CBD Adjunctive Therapies

NSG 6999 W2 D10 -CBD Adjunctive Therapies

Background question:

What are the therapeutic treatment options of cannabinol oil (CBD) as adjunctive therapies for chronic pain management?

 

The therapeutic response to managing chronic pain is not only with medications. Alternatives to treatment of chronic pain include massage. Therapies such as reducing stress with meditation and massage have been proven to reduce the quality of chronic musculoskeletal pain. Albeit not a cure, such benefits to therapeutic massage in relation to chronic pain do exist. Chronic pain can affect an individual’s psychological health, therefore mindful stress reduction is beneficial in improving the overall health status of the individual.

A study conducted found that improving the mental health status by mind reducing stress techniques can reduce the quality of pain. The use of therapeutic massage as adjunctive therapy for managing chronic pain displays a significantly higher reduction in pain.  The random cohort study identified the treatment modalities in comparison with the standards of care for chronic pain management did influence the patients’ reported quality of pain (Plews-Ogan, Owens, Goodman, Wolfe,  & Schorling, 2005).

The cannabinoids (CBD) is from the marijuana plant however does not contain the psychoactive effect. Humans have a endocannabinoid system (ECS) which consists of cannabinoid receptors, endocannabinoids, and the enzymes responsible for degradation of the chemical components.  The cannabinoids affect both the CB1R and CB2R cannabinoid receptors. The CB1R receptor is predominantly found in the brain and is the most common metabotropic receptor, expressed in the hippocampus, basal ganglia, cortex and cerebellum. CBR1 is also present in muscle, nerve, and bone tissue throughout the human body. CB2R is also present but commonly found in the immune cells, skin, nerve fibers, bone cells, keratinocytes, liver, and somatostatin-secreting cells (La Porta, Bura., Negrete, & Maldonado (2014). Pain receptors and nociceptors are a large component of understanding pain. The sensation of pain and how that is transmitted through the body is a science.

Combining therapeutic massage with the use of products containing CBD oil will aid in the overall reduction in quality of pain. The use of multimodal adjunctive therapies are intended to assist in pain management, not to replace or become the primary source of pain control. One of the challenges I will face with the research topic chosen is there are limited studies based on the effectiveness of CBD oil and the therapeutic efficacy due to the use of the substance is relatively new. Another challenge I will face is explaining how adjunctive therapies are not intended to replace pain medication management of chronic pain management, but to assist in controlling the symptoms of pain.

KINDLY ORDER NOW FOR A CUSTOM-WRITTEN, PLAGIARISM-FREE PAPER

 

Reference:

FARLEY, K. (2019). CBD Oil for Anxiety and Pain Management. Access, 33(3), 11–13. Retrieved from https://search-ebscohost-com.southuniversity.libproxy.edmc.edu/login.aspx?direct=true&db=rzh&AN=135107756&site=eds-live

La Porta, C., Bura, S. A., Negrete, R., & Maldonado, R. (2014). Involvement of the endocannabinoid system in osteoarthritis pain. European Journal of Neuroscience, 39(3), 485–500. https://doi.org/10.1111/ejn.12468

Plews-Ogan, M., Owens, J. E., Goodman, M., Wolfe, P., & Schorling, J. (2005). A Pilot Study Evaluating Mindfulness-Based Stress Reduction and Massage for the Management of Chronic Pain. Journal of General Internal Medicine, 20(12), 1136–1138. https://doi.org/10.1111/j.1525-1497.2005.0247.x